β-cell dysfunction is associated with metabolic syndrome severity in adults

Metabolic Syndrome and Related Disorders

Volumn 12, Issue 2, 2014, Pages 79-85

  Malin, Steven K ^a,b   Finnegan, Stephen ^a   Fealy, Ciaran E ^a   Filion, Julianne ^a   Rocco, Michael B ^a   Kirwan, John P ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN-SECRETING CELLS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREDIABETIC STATE; SEVERITY OF ILLNESS INDEX;

EID: 84894502934     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2013.0083     Document Type: Article

References (33)

1. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745-2749
2. Kahn SE, Prigeon RL, Schwartz RS, et al. Obesity, body fat distribution, insulin sensitivity and islet beta-cell function as explanations for metabolic diversity. J Nutr 2001;131:354S- 360S.
3. Utzschneider KM, Prigeon RL, Faulenbach M, et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 2009;32:335-341
4. DeFronzo RA, Abdul Ghani MA. Preservation of b-cell function: The key to diabetes prevention. J Clin Endocrinol Metab 2011;96:2354-2366
5. Cubeddu LX, Hoffmann IS. Impact of traits of metabolic syndrome on beta-cell function and insulin resistance in normal fasting, normal glucose tolerant subjects. Metabol Synd Relat Disord 2012;10:344-350
6. Franks PW, Ekelund U, Brage S, et al. Does the association of habitual physical activity with the metabolic syndrome differ by level of cardiorespiratory fitness?. Diabetes Care 2004;27:1187-1193
7. Wijndaele K, Beunen G, Duvigneaud N, et al. A continuous metabolic syndrome risk score: Utility for epidemiological analyses. Diabetes Care 2006;29:2329-2329
8. Solomon TPJ, Haus JM, Kelly KR, et al. Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care 2010;33:1561-1566
9. Solomon TPJ, Haus JM, Kelly KR, et al. A low-glycemic index diet combined with exercise reduces insulin resistance, postprandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans. Am J Clin Nutr 2010;92:1359-1368
10. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit Pathw Cardiol 2005;4:198-203
11. Malin SK, Nightingale J, Choi S, et al. Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults. Obesity 2013;21:93-100
12. Bateman LA, Slentz CA, Willis LH, et al. Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise- STRRIDE-AT/RT). Am J Cardiol 2011;108:838-844
13. Johnson JL, Slentz CA, Houmard JA, et al. Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise). Am J Cardiol 2007;100:1759
14. McArdle WD, FI Katch, VL Katch. Exercise Physiology: Energy, Nutrition, and Human Performance, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2007
15. O'Leary VB, Marchetti CM, Krishnan RK, et al. Exerciseinduced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol 2006; 100:1584-1589
16. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419
17. MatsudaM, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470
18. Phillips DI, Clark PM, Hales CN, et al. Understanding oral glucose tolerance: Comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabetic Med 1994;11:286-292
19. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993;42:1663-1672
20. Dela F, Stallknecht B. Effect of physical training on insulin secretion and action in skeletal muscle and adipose tissue of first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 2010;299:E80-E91
21. Kahn SE, Larson VG, Beard JC, et al. Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging. Am J Physiol 1990;258:E937-E943
22. Toft Nielsen MB, Damholt MB, Madsbad S, et al. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 2001;86: 3717-3723
23. Poitout V, Robertson RP. Minireview: Secondary beta-cell failure in type 2 diabetes-A convergence of glucotoxicity and lipotoxicity. Endocrinology 2002;143:339-342
24. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495
25. Cobelli C, Toffolo GM, Dalla Man C, et al. Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 2007;293: E1-E15
26. Basu R, Dalla Man C, Campioni M, et al. Effects of age and sex on postprandial glucose metabolism: Differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes 2006;55:2001-2014
27. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-846
28. Muzumdar R, Ma X, Atzmon G, et al. Decrease in glucosestimulated insulin secretion with aging is independent of insulin action. Diabetes 2004;53:441-446
29. McGarry JD. Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002;51:7-18
30. Kashyap SR, Belfort R, Gastaldelli A, et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003;52:2461-2474
31. Hribal ML, Perego L, Lovari S, et al. Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans. FASEB J 2003;17: 1340-1342
32. Perreault L, Kahn SE, Christophi CA, et al. Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care 2009;32:1583-1588
33. Haffner SM, D'Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispancis compared with non-Hispanic whites. The Insulin Resistance Study. Diabetes 1996;45:742-748